Cytomegalovirus infection/disease after hematopoietic stem cell transplantation

Abstract Cytomegalovirus (CMV) disease has historically been a main cause of death after allogeneic hematopoietic stem cell transplantation (HSCT). Since the introduction of prophylactic or preemptive therapy against CMV, the incidence of CMV disease has been successfully reduced. However, breakthro...
Ausführliche Beschreibung

Gespeichert in:
Autor*in:

Mori, Takehiko [verfasserIn]

Kato, Jun

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2010

Schlagwörter:

Cytomegalovirus

Hematopoietic stem cell transplantation

CMV antigenemia

Preemptive therapy

Prophylactic therapy

Real-time PCR

Ganciclovir

Foscarnet

Immunotherapy

Anmerkung:

© The Japanese Society of Hematology 2010

Übergeordnetes Werk:

Enthalten in: International journal of hematology - Tokyo [u.a.] : Springer, 1995, 91(2010), 4 vom: 23. Apr., Seite 588-595

Übergeordnetes Werk:

volume:91 ; year:2010 ; number:4 ; day:23 ; month:04 ; pages:588-595

Links:

Volltext

DOI / URN:

10.1007/s12185-010-0569-x

Katalog-ID:

SPR02510490X

Nicht das Richtige dabei?

Schreiben Sie uns!